Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | superoxide dismutase, putative | 0.0084 | 0.0064 | 0.5946 |
Trypanosoma brucei | iron superoxide dismutase | 0.0116 | 0.0108 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0122 | 0.0117 | 0.0009 |
Trypanosoma cruzi | iron superoxide dismutase A, mitochondrial | 0.0116 | 0.0108 | 1 |
Toxoplasma gondii | superoxide dismutase SOD3 | 0.0116 | 0.0108 | 0.5 |
Trypanosoma brucei | iron superoxide dismutase A, mitochondrial | 0.0116 | 0.0108 | 1 |
Trypanosoma cruzi | superoxide dismutase, putative | 0.0084 | 0.0064 | 0.5946 |
Trypanosoma brucei | iron superoxide dismutase | 0.0116 | 0.0108 | 1 |
Trichomonas vaginalis | superoxide dismutase, putative | 0.0116 | 0.0108 | 0.5 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 0.7333 | 1 | 1 |
Trypanosoma cruzi | iron superoxide dismutase, putative | 0.0116 | 0.0108 | 1 |
Entamoeba histolytica | iron-containing superoxide dismutase | 0.0116 | 0.0108 | 0.5 |
Mycobacterium ulcerans | superoxide dismutase [Fe] SodA | 0.0116 | 0.0108 | 0.5 |
Onchocerca volvulus | Superoxide dismutase [Mn], mitochondrial homolog | 0.0116 | 0.0108 | 1 |
Mycobacterium tuberculosis | Superoxide dismutase [FE] SodA | 0.0116 | 0.0108 | 0.5 |
Mycobacterium leprae | Probable superoxide dismutase SodA | 0.0116 | 0.0108 | 0.5 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 0.7333 | 1 | 1 |
Trypanosoma cruzi | iron superoxide dismutase, putative | 0.0116 | 0.0108 | 1 |
Trichomonas vaginalis | iron superoxide dismutase A, putative | 0.0116 | 0.0108 | 0.5 |
Plasmodium falciparum | superoxide dismutase [Fe] | 0.0606 | 0.078 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.7333 | 1 | 1 |
Trypanosoma cruzi | iron superoxide dismutase, putative | 0.0116 | 0.0108 | 1 |
Toxoplasma gondii | superoxide dismutase | 0.0116 | 0.0108 | 0.5 |
Plasmodium vivax | superoxide dismutase [Fe], putative | 0.0606 | 0.078 | 1 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 0.7333 | 1 | 1 |
Trypanosoma brucei | superoxide dismutase, putative | 0.0084 | 0.0064 | 0.5946 |
Trypanosoma cruzi | superoxide dismutase, putative | 0.0084 | 0.0064 | 0.5946 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0122 | 0.0117 | 0.0009 |
Leishmania major | iron superoxide dismutase, putative | 0.0116 | 0.0108 | 1 |
Wolbachia endosymbiont of Brugia malayi | superoxide dismutase, SodA | 0.0116 | 0.0108 | 0.5 |
Leishmania major | iron superoxide dismutase, putative | 0.0116 | 0.0108 | 1 |
Trypanosoma brucei | iron superoxide dismutase C, mitochondrial | 0.0084 | 0.0064 | 0.5946 |
Trichomonas vaginalis | superoxide dismutase [fe], putative | 0.0116 | 0.0108 | 0.5 |
Trichomonas vaginalis | superoxide dismutase [fe], putative | 0.0116 | 0.0108 | 0.5 |
Trichomonas vaginalis | superoxide dismutase [mn], putative | 0.0116 | 0.0108 | 0.5 |
Trichomonas vaginalis | superoxide dismutase, putative | 0.0116 | 0.0108 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0122 | 0.0117 | 0.0009 |
Trypanosoma cruzi | iron superoxide dismutase, putative | 0.0069 | 0.0044 | 0.4054 |
Leishmania major | iron superoxide dismutase | 0.0116 | 0.0108 | 1 |
Trichomonas vaginalis | superoxide dismutase [fe], putative | 0.0116 | 0.0108 | 0.5 |
Toxoplasma gondii | superoxide dismutase SOD2 | 0.0116 | 0.0108 | 0.5 |
Onchocerca volvulus | Superoxide dismutase [Mn], mitochondrial homolog | 0.0116 | 0.0108 | 1 |
Trypanosoma cruzi | iron superoxide dismutase A, mitochondrial | 0.0116 | 0.0108 | 1 |
Trypanosoma cruzi | superoxide dismutase, putative | 0.0084 | 0.0064 | 0.5946 |
Chlamydia trachomatis | superoxide dismutase | 0.0116 | 0.0108 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Increase (functional) | 0 % | Anticonvulsant activity of the compound was determined by using rat MEST test at 2 mg/kg p.o. 2 hr post-dose; ND : not determined | ChEMBL. | 12729628 |
Log Ki (functional) | = 7.3 | Binding affinity at [3H]-SB-204,269 binding site expressed as pKi | ChEMBL. | 12729628 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.